ChemPartner PharmaTech Co.,Ltd.

SZSE:300149 Stock Report

Market Cap: CN¥3.8b

ChemPartner PharmaTechLtd Management

Management criteria checks 0/4

ChemPartner PharmaTechLtd's CEO is Swee Lian Woo, appointed in Jan 2024, has a tenure of less than a year. directly owns 9.71% of the company’s shares, worth CN¥340.49M. The average tenure of the management team and the board of directors is 1.7 years and 2.5 years respectively.

Key information

Swee Lian Woo

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownership9.7%
Management average tenure1.7yrs
Board average tenure2.5yrs

Recent management updates

Recent updates

Is ChemPartner PharmaTechLtd (SZSE:300149) Using Debt In A Risky Way?

Dec 10
Is ChemPartner PharmaTechLtd (SZSE:300149) Using Debt In A Risky Way?

ChemPartner PharmaTech Co.,Ltd.'s (SZSE:300149) Price Is Right But Growth Is Lacking After Shares Rocket 51%

Sep 30
ChemPartner PharmaTech Co.,Ltd.'s (SZSE:300149) Price Is Right But Growth Is Lacking After Shares Rocket 51%

Improved Revenues Required Before ChemPartner PharmaTech Co.,Ltd. (SZSE:300149) Stock's 29% Jump Looks Justified

Aug 04
Improved Revenues Required Before ChemPartner PharmaTech Co.,Ltd. (SZSE:300149) Stock's 29% Jump Looks Justified

Chempartner Pharmatech Co., Ltd.'s (SZSE:300149) Share Price Boosted 29% But Its Business Prospects Need A Lift Too

Mar 08
Chempartner Pharmatech Co., Ltd.'s (SZSE:300149) Share Price Boosted 29% But Its Business Prospects Need A Lift Too

CEO

Swee Lian Woo (63 yo)

less than a year

Tenure

Mr. Swee Lian Woo is President of Perfect (China) Co., Ltd. He is Director of RRTC, Inc. He serves as General Manager and Chairman of Chempartner Pharmatech Co., Ltd. since January 10, 2024.He was Chairma...

Leadership Team

NamePositionTenureCompensationOwnership
Jian Xu
Board Secretary3.1yrsCN¥1.44mno data
Zhenjia Chen
Vice President1.7yrsCN¥1.78mno data
Swee Lian Woo
GM & Chairmanless than a yearno data9.71%
CN¥ 365.1m

1.7yrs

Average Tenure

63yo

Average Age

Experienced Management: 300149's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Swee Lian Woo
GM & Chairmanless than a yearno data9.71%
CN¥ 365.1m
Xin Hui
Director6.4yrsCN¥360.00kno data
Xuemei Zhang
Independent Directorless than a yearno datano data
Rong Yu
Directorless than a yearno datano data
Dachao Zhang
Chairman of the Supervisory Board3.3yrsno datano data
Zhicheng Guo
Independent Director4.3yrsCN¥80.00kno data
Shi Xin Fan
Director3.1yrsCN¥1.03mno data
Xianzhong Wang
Independent Director3.3yrsCN¥80.00k0.00030%
CN¥ 11.3k
Jiahui Qi
Supervisor6.4yrsno data0.0085%
CN¥ 318.5k
Ling Yang
Independent Director2yrsCN¥80.00kno data
Man Ngar Wong
Employee Supervisor1.8yrsno datano data
Wanglong Chen
Non-Independent Directorless than a yearno datano data

2.5yrs

Average Tenure

53.5yo

Average Age

Experienced Board: 300149's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 13:43
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ChemPartner PharmaTech Co.,Ltd. is covered by 7 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Qiwei WangChangjiang Securities Co. LTD.
Feifei XuChina Merchants Securities Co. Ltd.
Xiaofeng LiuChina Minzu Securities